中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
1期
3-4
,共2页
脑卒中%继发性癫痫%临床特点%防治措施
腦卒中%繼髮性癲癇%臨床特點%防治措施
뇌졸중%계발성전간%림상특점%방치조시
Stroke%Secondary epilepsy%Clinical features%Prevention measures
目的探讨脑卒中后继发性癫痫的临床特点和防治措施.方法回顾性分析2009年1月至2012年1月我院收治的48例经 CT 和(或) MRI 证实的脑卒中后继发性癫痫患者临床资料.结果我院 EP 发生率为8.33%.蛛网膜下腔出血继发性癫痫发病率最高为17.9%,其次为混合性卒中、脑出血、脑梗死,分别为15.4%、9.7%、3.6%;早发性癫痫占70.8%,迟发性癫痫占29.2%;病灶发生部位以皮质病变为主占80.3%,明显高于其他发病部位(P <0.01).结论 EP 的发生与卒中类型、病程、病变部位及用药等密切相关,了解卒中后癫痫的发病特点及相关性,利于指导治疗、评价预后、降低病死率.晚期发作需长期抗癫痫药物治疗.
目的探討腦卒中後繼髮性癲癇的臨床特點和防治措施.方法迴顧性分析2009年1月至2012年1月我院收治的48例經 CT 和(或) MRI 證實的腦卒中後繼髮性癲癇患者臨床資料.結果我院 EP 髮生率為8.33%.蛛網膜下腔齣血繼髮性癲癇髮病率最高為17.9%,其次為混閤性卒中、腦齣血、腦梗死,分彆為15.4%、9.7%、3.6%;早髮性癲癇佔70.8%,遲髮性癲癇佔29.2%;病竈髮生部位以皮質病變為主佔80.3%,明顯高于其他髮病部位(P <0.01).結論 EP 的髮生與卒中類型、病程、病變部位及用藥等密切相關,瞭解卒中後癲癇的髮病特點及相關性,利于指導治療、評價預後、降低病死率.晚期髮作需長期抗癲癇藥物治療.
목적탐토뇌졸중후계발성전간적림상특점화방치조시.방법회고성분석2009년1월지2012년1월아원수치적48례경 CT 화(혹) MRI 증실적뇌졸중후계발성전간환자림상자료.결과아원 EP 발생솔위8.33%.주망막하강출혈계발성전간발병솔최고위17.9%,기차위혼합성졸중、뇌출혈、뇌경사,분별위15.4%、9.7%、3.6%;조발성전간점70.8%,지발성전간점29.2%;병조발생부위이피질병변위주점80.3%,명현고우기타발병부위(P <0.01).결론 EP 적발생여졸중류형、병정、병변부위급용약등밀절상관,료해졸중후전간적발병특점급상관성,리우지도치료、평개예후、강저병사솔.만기발작수장기항전간약물치료.
Objective To investigate the clinical characteristics of secondary epilepsy after stroke and prevention measures. Methods A retrospective analysis of 48 cases from January 2009 to January 2012 in our hospital CT and (or) MRI confirmed post-stroke patients with secondary epilepsy clinical data. Results The hospital EP incidence rate of 8.33%. Subarachnoid hemorrhage secondary epilepsy incidence of up to 17.9%, followed by mixed stroke, cerebral hemorrhage, cerebral infarction, respectively, 15.4%, 9.7%, 3.6%; 70.8% of early-onset epilepsy, tardive epilepsy, 29.2%; the lesion occurrence site mainly cortical lesions (80.3%) was significantly higher than that of other diseased parts (P<0.01). Conclusion EP occurrence and type of stroke, duration of the lesion and drug use is closely related to the understanding of stroke epilepsy after onset characteristics and relevance, which will help guide treatment, prognostic evaluation, and reduce mortality. The late onset requires long-term antiepileptic drug therapy.